EE69 Health and Economic Outcomes of Botulinum Toxin-a Products for Adult Patients with UPPER LIMB Spasticity in a Real-World Setting

J Jacinto,S Ashford,K Fheodoroff,N Danchenko,F Calvi-Gries,Y Bourhis,Jd Whalen,G Pietri,L Turner-Stokes

doi:10.1016/j.jval.2022.04.323

EE69 Health and Economic Outcomes of Botulinum Toxin-a Products for Adult Patients with UPPER LIMB Spasticity in a Real-World Setting

J Jacinto, S Ashford + Show 7 more

Open Access

https://doi.org/10.1016/j.jval.2022.04.323

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Jun 25, 2022
License type: publisher-specific-oa

#Upper Limb Spasticity #Botulinum Toxin A + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Botulinum toxin A (BoNT-A) can enable achievement of treatment goals in upper limb spasticity (ULS). However, real-world data are limited. We examine health and economic outcomes of BoNT-A in ULS in the real-world.

Full Text